Twinbeech Capital LP Acquires Shares of 28,123 The Clorox Company (NYSE:CLX)

Twinbeech Capital LP purchased a new position in shares of The Clorox Company (NYSE:CLX - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 28,123 shares of the company's stock, valued at approximately $4,567,000.

Several other hedge funds and other institutional investors have also bought and sold shares of CLX. Two Sigma Advisers LP bought a new position in shares of Clorox during the fourth quarter valued at about $10,459,000. Two Sigma Investments LP bought a new stake in Clorox in the fourth quarter worth $16,040,000. Tidal Investments LLC grew its position in Clorox by 5.9% during the 4th quarter. Tidal Investments LLC now owns 31,665 shares of the company's stock valued at $5,143,000 after purchasing an additional 1,752 shares during the last quarter. Teza Capital Management LLC increased its position in shares of Clorox by 766.4% during the fourth quarter. Teza Capital Management LLC now owns 13,741 shares of the company's stock valued at $2,232,000 after acquiring an additional 12,155 shares in the last quarter. Finally, Tang Capital Management LLC lifted its holdings in shares of Clorox by 386.6% during the fourth quarter. Tang Capital Management LLC now owns 6,014 shares of the company's stock valued at $977,000 after purchasing an additional 4,778 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company's stock.

Clorox Stock Performance

Shares of NYSE CLX traded up $0.07 during midday trading on Friday, reaching $130.97. The company had a trading volume of 1,243,078 shares, compared to its average volume of 1,331,829. The stock has a market cap of $16.14 billion, a P/E ratio of 35.78, a P/E/G ratio of 2.62 and a beta of 0.60. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37. The business's 50-day simple moving average is $139.91 and its 200 day simple moving average is $152.60.

Clorox (NYSE:CLX - Get Free Report) last issued its earnings results on Monday, May 5th. The company reported $1.45 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.57 by ($0.12). The firm had revenue of $1.67 billion during the quarter, compared to analysts' expectations of $1.74 billion. Clorox had a return on equity of 316.87% and a net margin of 6.38%. The business's revenue was down 8.0% on a year-over-year basis. During the same quarter last year, the business earned $1.71 EPS. On average, analysts forecast that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd were issued a $1.22 dividend. This represents a $4.88 annualized dividend and a yield of 3.73%. The ex-dividend date was Wednesday, April 23rd. Clorox's payout ratio is 87.61%.

Analyst Ratings Changes

Several research firms have recently commented on CLX. JPMorgan Chase & Co. decreased their price objective on Clorox from $151.00 to $144.00 and set a "neutral" rating on the stock in a research note on Tuesday, May 6th. DA Davidson reduced their price target on Clorox from $171.00 to $169.00 and set a "neutral" rating on the stock in a report on Wednesday, February 5th. UBS Group lowered their price objective on shares of Clorox from $176.00 to $154.00 and set a "neutral" rating for the company in a research report on Thursday, April 17th. Wells Fargo & Company reduced their target price on shares of Clorox from $145.00 to $142.00 and set an "equal weight" rating on the stock in a research report on Tuesday, May 6th. Finally, Morgan Stanley reduced their price objective on Clorox from $165.00 to $150.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. Three analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has given a buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $151.23.

Insiders Place Their Bets

In related news, Director Pierre R. Breber bought 4,000 shares of the company's stock in a transaction that occurred on Wednesday, May 7th. The shares were purchased at an average cost of $136.57 per share, with a total value of $546,280.00. Following the completion of the acquisition, the director now directly owns 4,000 shares in the company, valued at approximately $546,280. The trade was a ∞ increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.57% of the stock is owned by insiders.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.